Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci?

J Antimicrob Chemother. 2000 May;45(5):715. doi: 10.1093/jac/45.5.715.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aminoglycosides
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Clindamycin / pharmacology
  • Clindamycin / therapeutic use*
  • Drug Resistance, Microbial
  • Erythromycin / pharmacology
  • Female
  • Humans
  • Male
  • Methicillin Resistance
  • Middle Aged
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Clindamycin
  • Erythromycin